跳至主要内容
临床试验/NCT02975999
NCT02975999已完成2 期

Use of Vasopressin Following the Fontan Operation: Both Pilot and Multicenter Studies

Wake Forest University Health Sciences1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2016年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
12
试验地点
1
主要终点
Chest Tube Drainage

研究概览

简要总结

The purpose of this pilot study is to prepare for a larger study to determine whether Vasopressin following the Fontan operation will decrease chest tube output and duration.

详细描述

A pilot randomized, double blinded clinical trial to evaluate the use of vasopressin following the Fontan operation.

Phase one of the study will be a single center pilot study and will be conducted at Advocate Children's Hospital, Oak Lawn IL. This will be a randomized and double blinded. Ten patients will be enrolled with five patients as control group and five receiving Vasopressin. Vasopressin levels will be obtained just prior to initiation of Vasopressin and 48 hours later in the pilot study. Safety and effect size will be evaluated after this pilot study.

Drug administration protocol:

Vasopressin at a dose of 0.4 mU/kg/min will be started on subjects in the study group while coming off cardiopulmonary bypass. The dose of Vasopressin will not be titrated. Study drug drip will infuse for 48 hours after which will be discontinued.

The placebo group will be receiving normal saline at the same rate of the vasopressin group. The treating physician will be blinded.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Months 至 7 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Subjects between 1.5-7 years old undergoing Fontan operation.

排除标准

  • Patients with a planned fenestrated Fontan.
  • Patients undergoing revision surgery for failing Fontan.
  • Evidence of renal insufficiency prior to surgery defined by creatinine >1 mg/dl.
  • Planned arch reconstruction at the time of the Fontan procedure

研究组 & 干预措施

Vasopressin

Experimental

Vasopressin at 0.4mU/kg/min

干预措施: Vasopressin (Drug)

Normal saline

Placebo Comparator

Normal saline will be provided on a drip infusion to the selected group once coming off cardiopulmonary bypass following the Fontan operation.

干预措施: Normal Saline (Drug)

结局指标

主要结局

Chest Tube Drainage

时间窗: From post operative day 0 through study completion, an average of 1 month

chest tube drainage until the day the chest tube is removed

次要结局

  • Length of Hospital Stay(From the day of the surgery (post operative day 0) through study completion, an average of 1 month)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验